BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3181076)

  • 1. [Sensitivity of human tumor heterografts to a spin-labelled rubomycin derivative].
    Konovalova NP; D'iachkovskaia RF; Ganieva LKh; Volkova LM; Lapshin IM
    Eksp Onkol; 1988; 10(4):54-9. PubMed ID: 3181076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subrenal capsule assay of human tumor chemosensitivity.
    Konovalova NP; Diatchkovskaya RF; Ganieva LKh; Volkova LM; Lapshin IM; Rudakov BYa ; Shaposhnikov YuG ; Shapiro AB
    Neoplasma; 1991; 38(3):275-84. PubMed ID: 1857448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The six-day subrenal capsule assay (SRCA) for testing the response of human tumours to anticancer agents. Validity and usefulness in cancer research and treatment.
    Aamdal S; Fodstad O; Pihl A
    Ann Chir Gynaecol Suppl; 1985; 199():51-9. PubMed ID: 3864392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum time sequence for the administration of cyclophosphamide and other drugs in vivo.
    Mattern J; Wauss K; Volm M
    Anticancer Res; 1985; 5(2):173-8. PubMed ID: 4039550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitroxyl derivatives of rubomycin].
    Emanuél' NM; Konovalova NP; D'iachkovskaia RF; Denisova LK
    Antibiotiki; 1982 Nov; 27(11):811-5. PubMed ID: 7181462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodological aspects of the 6-day subrenal capsule assay for measuring the response of human tumors to anticancer agents.
    Aamdal S; Fodstad O; Pihl A
    Anticancer Res; 1985; 5(4):329-37. PubMed ID: 4037730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xenograft of human bronchial squamous cell carcinoma and its sensitivity to therapy].
    Bak M; Sugár J
    Orv Hetil; 1984 Dec; 125(52):3161-4, 3167. PubMed ID: 6549406
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of the results of mono- and polychemotherapy of disseminated forms of breast cancer using the CMFVP program and anthracycline antibiotics (carminomycin and adriamycin)].
    Trishkina EA; Gershanovich ML; Pavlov KA; Danova LA; Labkovskiĭ BM
    Antibiotiki; 1983 Nov; 28(11):853-8. PubMed ID: 6689116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Olsuf'eva EN; Averbukh LA
    Antibiotiki; 1981 Nov; 26(11):813-6. PubMed ID: 6895688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of the 6-day subrenal capsule assay for sensitivity testing of antineoplastic chemotherapy in oral mucosa carcinoma].
    Fröhlich M; Rositzka R; Neubauer B
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(5):427-32. PubMed ID: 2529712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytostatic action of semisynthetic rubomycin derivatives].
    Volkolupova OP; Makukho LV
    Antibiotiki; 1982 Oct; 27(10):779-81. PubMed ID: 7149685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy].
    Duplan JF
    Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of a combination of dimethylnitrosourea and a carbohydrate derivative of nitrosourea (ADEKO) with cyclophosphamide in an experiment].
    Krutova TV; Kondradov AA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1984; (3):439-45. PubMed ID: 6747090
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subrenal capsule assay in immunocompetent mice--the inevitable role of histopathology in assessment of this method as a tool determining tumor sensitivity to cytostatic drugs.
    Marek J; Bechynĕ M
    Neoplasma; 1990; 37(1):23-30. PubMed ID: 2320176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of nitrosomethylurea derivatives in the combined chemotherapy of experimental tumors].
    Krutova TV; Ostrovskaia LA
    Eksp Onkol; 1986; 8(5):47-50. PubMed ID: 3780511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
    Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
    Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin.
    Trail PA; Willner D; Bianchi AB; Henderson AJ; TrailSmith MD; Girit E; Lasch S; Hellström I; Hellström KE
    Clin Cancer Res; 1999 Nov; 5(11):3632-8. PubMed ID: 10589780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.